V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 170009744 | 170003832 | null | 95.3 | null | null | 2020-07-11 | IBRUTINIB | null | null | LENALIDOMIDE | 100692840 |
| 170009887 | 170003834 | 1.77 | null | null | null | 2017-09-22 | Cisplatin + Pemetrexed | 02 | null | ATEZOLIZUMAB | 100881922 |
| 170010083 | 170003839 | null | 98 | Palliative (P) | null | 2019-09-05 | null | 02 | N | BEVACIZUMAB | 101575437 |
| 170010150 | 170003841 | null | null | null | null | 2019-11-22 | null | null | null | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 101176569 |
| 170010169 | 170003843 | null | null | null | 2017-06-05 | 2017-06-06 | CAPECITABINE + TEMOZOLOMIDE | 02 | null | CARBOPLATIN | 100192144 |
| 170010183 | 170003844 | 1.85 | 63.7 | 03 | null | 2021-02-09 | LENALIDOMIDE + dexamethasone. | N | N | DURVALUMAB | 101595901 |
| 170010292 | 170003849 | 1.7 | 94 | null | null | 2014-06-24 | CNS Medullo HR Cis/Vinc/Cyclo + PBSCR | null | null | DABRAFENIB + TRAMETINIB | 100282308 |
| 170010346 | 170003851 | null | null | null | null | 2017-10-14 | null | null | null | ATEZOLIZUMAB | 101747171 |
| 170010397 | 170003854 | 1.57 | 72 | 03 | null | 2019-02-26 | null | N | N | CYTARABINE + ETOPOSIDE + LOMUSTINE + MELPHALAN | 101370834 |
| 170010400 | 170003855 | null | null | null | 2020-06-11 | 2021-01-17 | CHOP R | 02 | null | LETROZOLE + PALBOCICLIB | 100064732 |
| 170010425 | 170003857 | null | null | null | null | 2020-12-11 | null | N | null | BENDAMUSTINE + OBINUTUZUMAB | 101510110 |
| 170010472 | 170003859 | null | null | 03 | null | 2019-01-08 | null | 02 | N | ABEMACICLIB + FULVESTRANT | 100047021 |
| 170010519 | 170003863 | null | null | null | null | 2020-12-30 | DA 3+8 | 01 | null | IRINOTECAN + MDG | 101554668 |
| 170010551 | 170003864 | 2.04 | 107 | Palliative (P) | null | 2020-02-03 | null | 02 | N | DURVALUMAB | 101204712 |
| 170010646 | 170003870 | 1.67 | 63 | null | 2016-09-02 | 2016-10-06 | Carboplatin + Paclitaxel + Pembrolizumab | 02 | null | RITUXIMAB | 101114624 |
| 170010744 | 170003873 | 1.75 | 82.3 | null | null | 2019-11-03 | Temozolomide 150mg/m2 | null | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100081239 |
| 170010825 | 170003877 | 1.61 | null | Adjuvant (A) | null | 2018-02-19 | null | 02 | N | DOCETAXEL + NINTEDANIB | 100260112 |
| 170010838 | 170003879 | null | null | null | 2018-08-17 | 2019-04-19 | TRANSPLANT MELPHALAN AUTOLOGOUS | null | null | LENALIDOMIDE | 101264623 |
| 170010873 | 170003880 | null | 60.4 | 03 | null | 2018-03-31 | Liposomal Doxorubicin 40mg/m2 | 2 | N | LENALIDOMIDE | 100461226 |
| 170010962 | 170003883 | null | null | null | null | 2021-12-09 | Carboplatin + Etoposide IV 3 day | null | null | BEVACIZUMAB | 101566201 |
| 170011005 | 170003886 | null | null | Palliative (P) | 2017-03-12 | 2017-03-23 | CYCLOPHOSPHAMIDE + LENALIDOMIDE | 02 | N | CNS GCT II NON GERMIN - STD PEI CYCLOPHOSPHAMIDE | 100114680 |
| 170011014 | 170003887 | null | null | null | null | 2017-10-27 | null | null | null | TRIAL UNSPECIFIED | 101814405 |
| 170011034 | 170003888 | null | null | null | 2019-08-30 | 2019-10-14 | Bendamustine + Obinutuzumab | null | null | CLADRIBINE | 101517161 |
| 170011039 | 170003889 | 1.61 | 84.3 | null | null | 2014-01-05 | Capecitabine | 02 | null | CNS LGG 2004 03 CONS VINC + CARBO | 100761872 |
| 170011223 | 170003893 | 1.71 | 79.5 | null | null | 2018-12-08 | null | null | null | AML16 TRIAL | 100569607 |
| 170011247 | 170003895 | 1.51 | 25.5 | 03 | null | 2019-03-09 | null | 02 | N | ETOPOSIDE + IFOSFAMIDE | 100697869 |
| 170011284 | 170003897 | null | null | Palliative (P) | 2020-06-01 | 2020-06-01 | Carboplatin + Paclitaxel + Pembrolizumab | 02 | N | BLEOMYCIN + CISPLATIN + ETOPOSIDE + PACLITAXEL | 100918751 |
| 170011292 | 170003899 | null | null | 03 | null | 2019-11-11 | null | 02 | N | CYCLOPHOSPHAMIDE | 101476964 |
| 170011325 | 170003902 | null | 85.8 | null | 2019-10-06 | 2020-01-01 | Carboplatin + Pemetrexed | 02 | null | CNS LGG 2004 03 CONS VINC + CARBO | 100116314 |
| 170011328 | 170003903 | 1.55 | 73.2 | null | null | 2020-09-14 | null | null | null | TRIAL UNSPECIFIED | 101197057 |
| 170011338 | 170003904 | null | null | Adjuvant (A) | null | 2018-09-12 | null | null | N | GEMCITABINE | 100613661 |
| 170011346 | 170003905 | null | null | null | null | 2017-10-23 | null | null | null | IXAZOMIB + LENALIDOMIDE | 101728251 |
| 170011458 | 170003912 | 1.73 | 61.7 | null | null | 2021-06-03 | null | 02 | null | TEMOZOLOMIDE | 100324965 |
| 170011477 | 170003914 | null | 50.5 | null | 2021-07-30 | 2021-07-30 | CISPLATIN + VINORELBINE | 02 | null | DURVALUMAB | 101058998 |
| 170011538 | 170003916 | 1.65 | 60.9 | null | null | 2020-08-28 | null | null | null | OCTREOTIDE | 101677743 |
| 170011582 | 170003917 | null | 55.2 | null | null | 2022-03-09 | null | null | null | DURVALUMAB | 100282627 |
| 170011810 | 170003928 | null | null | null | null | 2020-04-16 | null | null | null | TOPOTECAN | 101542105 |
| 170011853 | 170003930 | null | null | null | null | 2020-06-11 | Bevacizumab | null | null | TRANSPLANT ALEMTUZUMAB + CYCLOPHOSPHAMIDE (+/- TBI) | 101842195 |
| 170011854 | 170003931 | 1.65 | 65.7 | null | 2019-06-18 | 2019-07-03 | null | null | null | TEMOZOLOMIDE | 100836278 |
| 170011946 | 170003936 | 1.83 | 50.3 | Curative (C) | null | 2017-08-30 | Docetaxel 75mg/m2 (21 day) | 2 | N | AML19 TRIAL | 100240806 |
| 170011981 | 170003938 | null | null | null | null | 2022-04-23 | null | 02 | null | CISPLATIN + VINORELBINE | 100651329 |
| 170011988 | 170003939 | null | null | null | null | 2018-11-08 | Pazopanib | 02 | null | DURVALUMAB | 101078223 |
| 170012007 | 170003940 | null | null | null | 2021-03-08 | 2021-03-15 | TRANSPLANT MELPHALAN AUTOLOGOUS | null | null | GEMCITABINE | 100099363 |
| 170012042 | 170003943 | 1.83 | 61.1 | null | null | 2019-06-20 | PCV | null | null | LENALIDOMIDE | 100103713 |
| 170012048 | 170003945 | null | null | null | 2022-01-01 | 2022-02-15 | Temozolomide 200mg/m2 | null | null | TEMOZOLOMIDE | 101331597 |
| 170012049 | 170003946 | null | null | Adjuvant (A) | null | 2018-06-19 | Bevacizumab | null | N | FLUOROURACIL + OXALIPLATIN | 100159964 |
| 170012097 | 170003948 | 1.55 | 49.7 | null | null | 2018-10-24 | null | 02 | null | DURVALUMAB | 100196912 |
| 170012101 | 170003950 | null | null | 03 | null | 2018-10-04 | null | null | N | LENALIDOMIDE | 100540494 |
| 170012144 | 170003951 | 1.6 | 65.7 | null | null | 2022-02-10 | null | null | null | CYCLOPHOSPHAMIDE | 101851231 |
| 170012153 | 170003953 | 1.82 | null | null | 2020-11-28 | 2020-12-12 | Temozolomide 150mg/m2 | null | null | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 101439168 |